PW

Pernilla Wittung-Stafshede

Director at Oblique Therapeutics

Since Ph D 1996, worked 12 years in the USA at the California Institute of Technology, Tulane University, and Rice University, since 7 years as a professor at Umeå University and from 2015 professor at Chalmers. Scientific expertise and experimental research on the biophysics of proteins with a focus today on proteins in cancer and neurodegeneration. Published over 250 scientific articles. A number of international and national assignments over the years, such as the Biophysical Society's board, KAW, VR (NT Council 2010-2012). Leads Genie, a major gender equality initiative, at Chalmers since 2019. Member of KVA, IVA and the Nobel Prize Committee for Chemistry. Advisor to the Nobel Museum and scientific advisor Axial Therapeutics.

Timeline

  • Director

    Current role